Current and future avoidable cost of smoking - Estimates for Sweden 2007

Health Policy

Volumn 103, Issue 1, 2011, Pages 83-91

  Bolin, Kristian ^a   Borgman, Benny ^b   Gip, Christina ^b   Wilson, Koo ^c  

^a LUND UNIVERSITY   (Sweden)

^b PFIZER INC   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Avoidable cost of smoking; Cost of smoking; Pharmaceutical cost; Smoking attributable mortality

Indexed keywords

ARTICLE; CIGARETTE SMOKING; HEALTH CARE COST; HUMAN; LIFESPAN; MORBIDITY; MORTALITY; PUBLIC HEALTH SERVICE; SENSITIVITY ANALYSIS; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FORECASTING; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; MODELS, STATISTICAL; RISK FACTORS; SMOKING; SWEDEN;

EID: 80054785555     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2011.08.011     Document Type: Article

References (33)

1. Royal College of Physicians Smoking and Health Summary and report of the Royal College of Physicians of London on smoking in relation to cancer of the lung and other diseases 1962, Pitman Publishing, New York.
2. Fagerström K. The epidemiology of smoking. Health consequences and benefits of cessation. Drugs 2002, 62(Suppl. 2):1-9.
3. Woolacott N.F., Jones L., Forbes C.A., Mather L.C., Sowden A.J., Song F.J., et al. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technology Assessment 2002, 6(16):1-245.
4. Keating G.M., Lyseng-Williamson K.A. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation. Pharmacoeconomics 2010, 28(3):231-254.
5. Hughes J.R. How confident should we be that smoking cessation treatments work?. Addiction 2009, 104(10):1637-1640.
6. World Health Organisation: report on the global tobacco epidemic; 2009: Implementing smoke-free environments.
7. Tobacco control country profiles 2003, The 12th World Conference on Tobacco or Health. 2nd ed. O. Shafey, S. Dolwick, G.E. Guindon (Eds.).
8. Abrams D.B., Graham A.L., Levy D.T., Mabry P.L., Orleans C.T. Boosting population quits through evidence-based cessation treatment and policy. American Journal of Preventive Medicine 2010, 38(March (Suppl. 3)):S351-S363.
9. Levy D.T., Graham A.L., Mabry P.L., Abrams D.B., Orleans C.T. Modeling the impact of smoking-cessation treatment policies on quit rates. American Journal of Preventive Medicine 2010, 38(3):S364-S372.
10. Lopez A.D., Collishaw N.E., Piha T. A descriptive model of the cigarette epidemic in developed countries. Tobacco Control 1994, 3:242-247.
11. Koopmanschap M.A. Cost-of-illness studies - useful for health policy?. Pharmacoeconomics 1998, 14(2):143-148.
12. Lundqvist G., Sandström H., Öhman A., Lars Weinehall Patterns of tobacco use: a 10-year follow-up study of smoking and snus habits in a middle-aged Swedish population. Scandinavian Journal of Public Health 2009, 37:161-167.
13. Patja K., Hakala S.M., Boström G., Nordgren P., Haglund M. Trends of tobacco use in Sweden and Finland: do differences in tobacco policy relate to tobacco use?. Scandinavian Journal of Public Health 2009, 37:153-160.
14. Lee P.N. Summary of the epidemiological evidence relating snus to health. Regulatory Toxicology and Pharmacology 2011, 59:197-214.
15. Hjalte K., Isacsson S.O., Lindgren B., Wilhelmsen L. Vad kostar tobaksbrukets medicinska skadeverkningar? (The economic impact of the negative health effects of smoking). Läkartidningen (Journal of the Swedish Medical Association) 1985, 82:2978-2981.
16. Bolin K., Lindgren B. Smoking, healthcare cost, and loss of productivity in Sweden 2001. Scandinavian Journal of Public Health 2007, 35:187-196.
17. Haglund M. Nordic tobacco control, towards smoke free societies 2003, Nordic Council of Ministers. K. Hakala, M. Waller (Eds.).
18. Bolin K., Mörk A.-C., Willers S., Lindgren B. Varenicline as compared to bupropion in smoking cessation therapy - cost-utility results for Sweden. Respiratory Medicine 2008, 102(5):699-710.
19. Adhikari B., Kahende J., Malarcher A., Pechacek T., Tong V. Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. Journal of the American Medical Association 2009, 301(6):593-594.
20. Howard P., Knight C., Boler A., Baker C. Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO simulation model: application to a population of US adult smokers. Pharmacoeconomics 2008, 26(6):497-511.
21. Thun M.J., Day-Lally C.A., Calle E.E., Flanders W.D., Heath C.H. Excess mortality among cigarette smokers: changes in a 20-year interval. American Journal of Public Health 1995, 85:1223-1230.
22. Thun M.J., Apicella L.F., Henley S.J. Smoking vs other risk factors as the cause of smoking-attributable deaths. Confounding in the courtroom. Journal of the American Medical Association 2000, 284:706-712.
23. Gavin NI, Wiesen C, Layton C. Review and meta-analysis of the evidence on the impact of smoking on perinatal conditions built into SAMMEC II. Final report to the National Centers for Chronic Disease Prevention and Health; 2001.
24. Swedish National Board of Health and Welfare. (a) Hospital Discharge Register; (b) Out-patient Care Register; (c) Cause of Death Register, and (d) Pharmaceutical Register; 2007.
25. Läkemedelsstatistik AB Medical Index Sweden 2003, Läkemedelsstatistik AB, Stockholm.
26. Apoteket AB Swedish Pharmaceutical Statistics 2007, Apoteket AB, Stockholm.
27. Swedish Social Insurance Agency. Newly Granted Early Retirements due to Permanent Disability, by Cause, Age, and Sex; 2007.
28. Statistics Sweden. (a) Life Tables; (b) Labour Force Survey; (c) Statistics on Incomes and Taxes; (d) Household Patterns of Time Use; (e) Consumer Price Index; 2007.
29. Allender S., Balakrishnan R., Scarborough P., Webster P., Rayner M. Tobacco Control 2009, 18(4):262-267.
30. Neubauer S., Welte R., Beiche A., Koenig H.H., Buesch K., Leidl R. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison. Tobacco Control 2006, 15:464-471.
31. Lundborg P. Does smoking increase sick leave? Evidence using register data on Swedish workers. Tobbaco Control 2007, 16:114-118.
32. Chaloupka F.J., Straif K., Leon M.E. Effectiveness of tax and price policies in tobacco control. Tobacco Control 2011, 20:235-238.
33. Lai T., Habicht J., Reinap M., Chisholm D., Baltussen R. Costs, health effects and cost-effectiveness of alcohol and tobacco control strategies in Estonia. Health Policy 2007, 84:75-88.